Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $97.07 million. The enterprise value is $72.88 million.
| Market Cap | 97.07M |
| Enterprise Value | 72.88M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.48 million shares outstanding. The number of shares has increased by 437.99% in one year.
| Current Share Class | 3.48M |
| Shares Outstanding | 3.48M |
| Shares Change (YoY) | +437.99% |
| Shares Change (QoQ) | +6.88% |
| Owned by Insiders (%) | 9.33% |
| Owned by Institutions (%) | 28.87% |
| Float | 1.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.32 |
| Forward PS | 1.28 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98
| Current Ratio | 1.98 |
| Quick Ratio | 1.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -51.34% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -53.85% |
| Weighted Average Cost of Capital (WACC) | 21.48% |
| Revenue Per Employee | $470,696 |
| Profits Per Employee | -$939,043 |
| Employee Count | 92 |
| Asset Turnover | 0.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.37% in the last 52 weeks. The beta is 3.13, so PTHS's price volatility has been higher than the market average.
| Beta (5Y) | 3.13 |
| 52-Week Price Change | +52.37% |
| 50-Day Moving Average | 27.39 |
| 200-Day Moving Average | 26.18 |
| Relative Strength Index (RSI) | 55.14 |
| Average Volume (20 Days) | 105,428 |
Short Selling Information
The latest short interest is 69,531, so 2.00% of the outstanding shares have been sold short.
| Short Interest | 69,531 |
| Short Previous Month | 27,790 |
| Short % of Shares Out | 2.00% |
| Short % of Float | 6.53% |
| Short Ratio (days to cover) | 0.96 |
Income Statement
In the last 12 months, PTHS had revenue of $43.30 million and -$86.39 million in losses. Loss per share was -$26.36.
| Revenue | 43.30M |
| Gross Profit | 32.81M |
| Operating Income | -56.75M |
| Pretax Income | -93.78M |
| Net Income | -86.39M |
| EBITDA | n/a |
| EBIT | -56.75M |
| Loss Per Share | -$26.36 |
Balance Sheet
The company has $24.19 million in cash and no debt, with a net cash position of $24.19 million or $6.96 per share.
| Cash & Cash Equivalents | 24.19M |
| Total Debt | n/a |
| Net Cash | 24.19M |
| Net Cash Per Share | $6.96 |
| Equity (Book Value) | -1.50M |
| Book Value Per Share | -0.42 |
| Working Capital | 31.40M |
Cash Flow
In the last 12 months, operating cash flow was -$35.08 million and capital expenditures -$293,000, giving a free cash flow of -$35.38 million.
| Operating Cash Flow | -35.08M |
| Capital Expenditures | -293,000 |
| Depreciation & Amortization | n/a |
| Net Borrowing | 45.02M |
| Free Cash Flow | -35.38M |
| FCF Per Share | -$10.18 |
Margins
Gross margin is 75.76%, with operating and profit margins of -131.06% and -199.50%.
| Gross Margin | 75.76% |
| Operating Margin | -131.06% |
| Pretax Margin | -216.56% |
| Profit Margin | -199.50% |
| EBITDA Margin | n/a |
| EBIT Margin | -131.06% |
| FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -437.99% |
| Shareholder Yield | -437.99% |
| Earnings Yield | -85.86% |
| FCF Yield | -35.16% |
Analyst Forecast
The average price target for PTHS is $53.14, which is 90.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.14 |
| Price Target Difference | 90.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 118.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |